COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells

Human immunodeficiency virus type 1 (HIV-1) gene transcription is characterized by two temporally distinct phases. While the initial phase relies solely on cellular transcription factors, the subsequent phase is activated by the viral Tat transactivator. We have previously reported that the subsequent phase of viral gene transcription can be repressed by the chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2 (CTIP2) in human microglial cells [O. Rohr, D. Lecestre, S. Chasserot-Golaz, C. Marban, D. Avram, D. Aunis, M. Leid and E. Schaeffer (2003), J. Virol., 77, 5415–5427]. Here, we demonstrate that CTIP proteins also repress the initial phase of HIV-1 gene transcription, mainly supported by the cellular transcription factors Sp1 and COUP-TF in microglial cells. We report that CTIP2 represses Sp1- and COUP-TF-mediated activation of HIV-1 gene transcription and viral replication as a result of physical interactions with COUP-TF and Sp1 in microglial nuclei. Using laser confocal microscopy CTIP2 was found to colocalize with Sp1, COUP-TF and the heterochromatin-associated protein Hp1α, which is mainly detected in transcriptionally repressed heterochromatic region. Moreover, we describe that CTIP2 can be recruited to the HIV-1 promoter via its association with Sp1 bound to the GC-box sequences of the long terminal repeat (LTR). Since our findings demonstrate that CTIP2 interacts with the HIV-1 proximal promoter, it is likely that CTIP2 promotes HIV-1 gene silencing by forcing transcriptionally repressed heterochromatic environment to the viral LTR region.

[1]  P. Dollé,et al.  CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis. , 2004, Gene expression patterns : GEP.

[2]  Ben Berkhout,et al.  The Human Immunodeficiency Virus Type 1 Promoter Contains a CATA Box Instead of a TATA Box for Optimal Transcription and Replication , 2004, Journal of Virology.

[3]  R. Bosch,et al.  Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression , 2004, AIDS.

[4]  M. Giacca,et al.  Nuclear organization and the control of HIV-1 transcription. , 2004, Gene.

[5]  D. Aunis,et al.  Regulation of HIV‐1 gene transcription: from lymphocytes to microglial cells , 2003, Journal of leukocyte biology.

[6]  S. Minucci,et al.  Involvement of the Histone Deacetylase SIRT1 in Chicken Ovalbumin Upstream Promoter Transcription Factor (COUP-TF)-interacting Protein 2-mediated Transcriptional Repression* , 2003, Journal of Biological Chemistry.

[7]  D. Aunis,et al.  Recruitment of Tat to Heterochromatin Protein HP1 via Interaction with CTIP2 Inhibits Human Immunodeficiency Virus Type 1 Replication in Microglial Cells , 2003, Journal of Virology.

[8]  E. Verdin,et al.  HIV reproducibly establishes a latent infection after acute infection of T cells in vitro , 2003, The EMBO journal.

[9]  Kuan-Teh Jeang,et al.  Tat and Trans-activation-responsive (TAR) RNA-independent Induction of HIV-1 Long Terminal Repeat by Human and Murine Cyclin T1 Requires Sp1* , 2003, The Journal of Biological Chemistry.

[10]  M. Leid,et al.  COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein. , 2002, The Biochemical journal.

[11]  Ben Berkhout,et al.  Synergistic Activation of Human Immunodeficiency Virus Type 1 Promoter Activity by NF-κB and Inhibitors of Deacetylases: Potential Perspectives for the Development of Therapeutic Strategies , 2002, Journal of Virology.

[12]  W. Greene,et al.  Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy , 2002, Nature Medicine.

[13]  J. Kappes,et al.  Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy , 2002, Antimicrobial Agents and Chemotherapy.

[14]  A. Jordan,et al.  The site of HIV‐1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation , 2001, The EMBO journal.

[15]  P. Chambon,et al.  Heterochromatin formation in mammalian cells: interaction between histones and HP1 proteins. , 2001, Molecular cell.

[16]  J. Kappes,et al.  Sensitivity of Human Immunodeficiency Virus Type 1 to the Fusion Inhibitor T-20 Is Modulated by Coreceptor Specificity Defined by the V3 Loop of gp120 , 2000, Journal of Virology.

[17]  M. Leid,et al.  Isolation of a Novel Family of C2H2 Zinc Finger Proteins Implicated in Transcriptional Repression Mediated by Chicken Ovalbumin Upstream Promoter Transcription Factor (COUP-TF) Orphan Nuclear Receptors* , 2000, The Journal of Biological Chemistry.

[18]  M. Churchill,et al.  A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. , 2000, Nucleic acids research.

[19]  D. Aunis,et al.  The Nuclear Receptor Chicken Ovalbumin Upstream Promoter Transcription Factor Interacts with HIV-1 Tat and Stimulates Viral Replication in Human Microglial Cells* , 2000, The Journal of Biological Chemistry.

[20]  D. Aunis,et al.  Functional Interactions between C/EBP, Sp1, and COUP-TF Regulate Human Immunodeficiency Virus Type 1 Gene Transcription in Human Brain Cells , 2000, Journal of Virology.

[21]  D. Aunis,et al.  CREB and COUP‐tF mediate transcriptional activation of the human immunodeficiency virus type 1 genome in jurkat t cells in response to cyclic AMP and dopamine , 1999, Journal of cellular biochemistry.

[22]  D. Aunis,et al.  Dopamine stimulates expression of the human immunodeficiency virus type 1 via NF-kappaB in cells of the immune system. , 1999, Nucleic acids research.

[23]  B. Chesebro,et al.  Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.

[24]  D. Dean,et al.  Rb Interacts with Histone Deacetylase to Repress Transcription , 1998, Cell.

[25]  D. Kolson,et al.  The effects of human immunodeficiency virus in the central nervous system. , 1998, Advances in virus research.

[26]  D. Aunis,et al.  COUP-TF and Sp1 Interact and Cooperate in the Transcriptional Activation of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat in Human Microglial Cells* , 1997, The Journal of Biological Chemistry.

[27]  F. Clavel,et al.  Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir. , 1997, AIDS.

[28]  D. Aunis,et al.  Chicken Ovalbumin Upstream Promoter Transcription Factor, a Transcriptional Activator of HIV-1 Gene Expression in Human Brain Cells* , 1996, The Journal of Biological Chemistry.

[29]  E. Wintersberger,et al.  Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F , 1996, Molecular and cellular biology.

[30]  K. H. Ng,et al.  Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglial cells with the SV40 large T antigen , 1995, Neuroscience Letters.

[31]  M. Garcia-Blanco,et al.  Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors , 1995, Journal of virology.

[32]  V. Perry,et al.  Biology of the mononuclear phagocyte system of the central nervous system and HIV infection , 1994, Journal of leukocyte biology.

[33]  G. Nabel,et al.  A cooperative interaction between NF‐kappa B and Sp1 is required for HIV‐1 enhancer activation. , 1993, The EMBO journal.

[34]  B. O’Malley,et al.  Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). , 1992, The Journal of biological chemistry.

[35]  L. Montagnier,et al.  Human microglial cells: Characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV‐1 infection , 1991, Annals of neurology.

[36]  B. Brew,et al.  Update on HIV-related neurological illness. , 1991, AIDS.

[37]  B. O’Malley,et al.  COUP transcription factor is a member of the steroid receptor superfamily , 1989, Nature.

[38]  D Harrich,et al.  Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat , 1989, Journal of virology.

[39]  A. Fauci,et al.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. , 1988, Science.

[40]  B. O’Malley,et al.  Purification and characterization of chicken ovalbumin upstream promoter transcription factor from HeLa cells. , 1987, The Journal of biological chemistry.

[41]  H. Gendelman,et al.  Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus , 1987, Journal of virology.

[42]  R. Tjian,et al.  Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. , 1986, Science.